You can help expand this article with text translated from the corresponding article in Japanese. (June 2018) Click [show] for important translation instructions.
Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia.
Consider adding a topic to this template: there are already 1,398 articles in the main category, and specifying|topic= will aid in categorization.
Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article.
You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing Japanese Wikipedia article at [[:ja:Meiji Seika ファルマ]]; see its history for attribution.
You may also add the template {{Translated|ja|Meiji Seika ファルマ}} to the talk page.
Meiji Seika Pharma Co., Ltd. (Meiji Seikaファルマ株式会社, Meiji Seika Faruma Kabushiki gaisha), formerly Meiji Seika Kaisha, Ltd. (明治製菓株式会社, Meiji Seika Kabushiki-gaisha) is a Japanese pharmaceutical company. It is currently a subsidiary of Meiji Holdings[1] and a Japanese leader in the area of infectious disease with 18% market share. It markets treatments for depression, obsessive-compulsive disorder, vaccines and allergy drugs. Meiji Pharma is doing research in generic anticancer drugs and biosimilars with partner organisations.[2]
On April 1, 2009, Meiji Seika Kaisha, Ltd. and Meiji Dairies Corporation established a joint holding company, Meiji Holdings, which is a constituent of the Nikkei 225 index. Two years later on the day, the food and healthcare business was taken over by Meiji Dairies to form "Meiji Co., Ltd.", and Meiji Seika was reorganized to a pharmaceutical company "Meiji Seika Pharma Co., Ltd."[citation needed] In 2014 Meiji acquired Medreich for $290 million, an Indian company active in selling generic pharmaceuticals to Europe, Asia and Africa.[4]
Logos
Old Meiji Seika brand logo (used from 1955 until March 2009)
